about
N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic reviewPharmacologic treatment of obsessive-compulsive disorder comorbidity.Pediatric obsessive-compulsive disorder: an update for advanced practice psychiatric nurses.Obsessive-compulsive disorder: Insights from animal models.From Treatment Response to Recovery - a Realistic Goal in OCDN-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current EvidenceAre Mentalizing Abilities and Insight Related to the Severity of Obsessive-Compulsive Disorder
P2860
Q34473631-1124CF52-AD94-4722-AC93-F372BCD7BC71Q38254003-BA8A88EB-8AF0-49B9-B8BF-51655EFF0CB7Q38426241-416A5228-6BED-44F1-8CD2-5AC381C1206FQ38832138-A220ABC6-8BF9-47B0-B228-78AF102E7F1AQ57161745-EC6A2B5D-8634-4CA4-888E-76DBA3BA9253Q58698161-CFD3E450-65D5-4995-A0D0-9AFC0343E745Q58732747-6BFC7E90-0741-4536-9F6B-7346F3B15DA7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging drugs to treat obsessive-compulsive disorder.
@en
type
label
Emerging drugs to treat obsessive-compulsive disorder.
@en
prefLabel
Emerging drugs to treat obsessive-compulsive disorder.
@en
P2093
P2860
P1476
Emerging drugs to treat obsessive-compulsive disorder.
@en
P2093
Andrea Cantisani
Giacomo Grassi
Stefano Pallanti
P2860
P356
10.1517/14728214.2014.875157
P407
P577
2013-12-31T00:00:00Z